<DOC>
	<DOC>NCT01717859</DOC>
	<brief_summary>The purpose of this research study is to determine if a change in inflammation or baseline inflammation seen on the ultrasound is a good indicator of how rheumatoid arthritis patients respond to TCZ 4mg/kg and whether early prediction of dose escalation is possible by utilizing ultrasound inflammatory measures.</brief_summary>
	<brief_title>Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>1. Patient must meet 1987 ACR criteria, 2. Age &gt; 18 years of age, 3. Baseline DAS28/ESR&gt;4.4, 4. Stable concomitant DMARDs, 5. Stable prednisone &lt;10mg or equivalent, and 6. Power Doppler score of &gt;=10</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>